Protective Immunity against SARS-CoV-2 Could Last Eight Months or More
Why declining antibodies to the novel coronavirus don't spell disaster for long-lasting immunity
Articles by La Jolla Institute for Immunology
Every COVID-19 Case Seems Different; These Scientists Want to Know Why
Scientists in the US and UK publish first in-depth look at how CD4+ T cells fight SARS-CoV-2
Scientists Identify Potential Targets for Immune Responses to SARS-CoV-2
Their analysis provides essential information for vaccine design and the evaluation of diagnostics and vaccine candidates
Western Diet Depletes Artery-Protecting Immune Cells
La Jolla Institute scientists show how immune cells that shield arteries from inflammation are reprogrammed into cells that promote inflammation by high levels of fats and cholesterol
Allergy Amplifier Implicated in Asthma Also Intensifies Food Allergy
La Jolla Institute researchers report that inhibitors of Histamine-Releasing Factor could block inflammatory response to food allergens
Scientists Develop New Way to Model Human Immune Variation in the Lab
Accounting for human immune diversity increases clinical relevance of fundamental immunological research; predicts susceptibility to inflammatory disease and cancer survival
Exhausted T Cells
Researchers map genome-wide changes that drive T cell maturation and exhaustion
New Study Indicates Why Children Are Likelier to Develop Food Allergies
LJI researcher explains how food tolerance emerges over time in normal individuals